FRAXA Finances - a look at the numbers over the past 3 years
2/1/2013
For 2013, FRAXA anticipates funding at least $1.2 million in research. Applications from scientists have arrived and are under review; we'll announce the new projects on April 1.
FRAXA's mission is to accelerate progress toward effective treatments and ultimately a cure for Fragile X. FRAXA has funded more than $22 million in research at universities all over the world.

Fundraising has been challenging over the past few years. But the driving force behind FRAXA is parents who are determined to help their children. We've kept overhead expenses very low in order to devote as many dollars as possible to Fragile X research!

2012  (not yet audited)    
Income Donations & Grants 1,390,944 (79%)  
  Fundraising 243,881 (14%)  
  Investments 120,183 (07%)  
  Product & Royalties 5,287 (00%)
fraxafinancials2012
    1,760,294 (100%)
     
Expenses Fundraising  82,254 (04%)
  Management and General 58,521 (03%)
  Program - Education 129,150 (07%)
  Program - Research 1,645,339 (86%)
Total Expenses   1,915,265 (100%)
Net Income   -154,971


2011      
Income Donations/Grants 1,109,353 (75%)  
  Fundraising 351,617 (24%)  
  Investments 9,913 (01%)  
  Product & Royalties 5,603 (00%)  
    1,476,486 (100%)
fraxafinancials2011
     
Expenses Fundraising  70,504 (04%)
  Management and General 57,378 (03%)
  Program - Education 99,408 (06%)
  Program - Research 1,583,573 (87%)
Total Expenses   1,810,864 (100%)
Net Income   -334,377
     

2010      
Income Donations/Grants 1,447,344 (73%)  
  Fundraising 398,272 (20%)  
  Investments 141,874 (07%)  
  Product & Royalties 8,214 (00%)
fraxafinancials2010
    1,995,704 (100%)
     
Expenses Fundraising  110,350 (06%)
  Management and General 58,403 (03%)
  Program - Education 100,132 (06%)
  Program - Research 1,483,119 (85%)
Total Expenses   1,752,003 (100%)
Net Income   243,701